577 results about "Cell survival rate" patented technology

Novel, nonagglomerated, engineered, ultra fine Cerium Oxide particles the size of approximately 2 to approximately 10 nm and methods for preparation of the particles. The resultant particles enhance the longevity of cells in culture. Applications of the particles include benefits for wound healing, treating arthritis and joint diseases, anti-aging and the treating of inflammations.

An objective of the present invention is to overcome a problem that there is an inverse relationship between the decellularization rate and the strength of tissue. This problem was solved by immersing tissue in a solution containing a non-micellar amphipathic molecule (e.g., a 1,2-epoxide polymer). Thus, the present invention provides decellularized tissue, in which the cell survival rate of the tissue is less than a level at which calcification or an immune reaction is elicited in an organism and the tissue damage rate of the tissue is suppressed to a level which permits clinical applications. Tissue prepared by the above-described treatment preferably retains a certain level of tissue strength. Further, the tissue of the present invention has an effect of performing cell replacement.

To provide an aqueous solution for cell preservation which is free of a natural animal-derived component such as a basal medium or serum. An aqueous preservation solution showing a high cell survival rate was obtained by removing a natural animal-derived component such as a basal medium or serum and controlling other components and their concentrations.

The invention provides a cell freezing medium. The cell freezing medium comprises acylated epsilon polylysine, polyhydric alcohols and equilibration buffer. According to the cell freezing medium disclosed by the invention, the polyhydric alcohols and acylated epsilon polylysine replace toxic dimethyl sulfoxide so as to serve as cryoprotective agents, so that damage to cells in the freezing resuscitation process is reduced, and the cell survival rate is improved. The invention further provides a method for performing freezing resuscitation on cells by utilizing the cell freezing medium and application of the method for freezing stem cells and immune cells. The method is simple and feasible to operate and is suitable for large-scale clinical application of cell therapy, and great convenienceis brought to clinical application of the cell freezing technology.

The invention provides a cryopreservation method and a resuscitation method of neural stem cells (NSCs), and provides a cryopreserved NSC solution and a resuscitated NSC solution with cell survival rates higher than 90%. The solutions are prepared with the methods provided by the invention. Also, the invention provides a cryopreservation medium and a resuscitation medium used in the NSC cryopreservation method and resuscitation method.

Coating materials for biological tissues which make it possible to preserve biological tissues over a long period of time; coated biological tissues with the use of the materials; and a method of coating biological tissues. A biological tissue is coated by using a coating material which contains at least a hydrogel-forming polymer and shows heat-reversible sol / gel transfer, i.e., being in the state of a sol at lower temperatures and setting to gel at higher temperatures. Thus a ratio A2 / A0 (wherein A0 represents the cell survival ratio of the biological tissue immediately before the coating, and A2 represents the cell survival ratio of the biological tissue 2 days after the coating) of 20% or more can be easily established.

The invention belongs to the field of cell frozen preservation, particularly relates to a cell frozen preservation solution and a cell frozen preservation method and provides a cell frozen preservation solution. The cell frozen preservation solution comprises a basic culture medium, a blood platelet lysate, bFGF and L-glutamine. The cell frozen preservation solution does not contain animal serum or DMSO, the possibility that an exogenous virus can be introduced by the animal serum is eliminated and the bad effect of the DMSO on adipose-derived stem cells is eliminated. Furthermore, the invention further provides the cell frozen preservation method. According to the method, complicated programmed cooling is not needed and operation is simple. After the adipose-derived stem cells are frozen and preserved by adopting the cell culture medium and the cell frozen preservation method for a year, the survival rate of the cells can reach 93% and the differentiation capacity of the adipose-derived stem cells is not affected.

The invention relates to polyethylene glycol monomethyl ether-poly 2-methyl-carboxyl propylene carbonate graft polyethyleneimine copolymer, a preparation method thereof and application thereof. The preparation method comprises the step of directly condensing carboxyl in the polyethylene glycol monomethyl ether-poly 2-methyl-carboxyl propylene carbonate graft polyethyleneimine segmented copolymer with amino in polyethyleneimine to form the graft copolymer. The copolymer is a polycation gene carrier, integrates the advantages of polyethylene glycol, Makrolan and polyethyleneimine, and has high transfection efficiency, wherein the highest transfection efficiency to the medium luciferase plasmid of african green monkey kidney cell is 14 times of that of American Invitrogen biological company transfection reagent Lipofetamine<TM>2000, can effectively antagonize the inhibiting effect of blood serum to the transfection, and has less cell toxicity, wherein consistency thereof is not higher than 200 microgramme / ml and cell survival rate is more than 80%.

The invention discloses an efficient CIK amplifying method, in particular to a method for cell populations, namely cytokine-induced killer cells utilizing in-vitro cell factors for efficiently inducing mononuclear cell expressions CD3 and CD56 of peripheral blood, wherein the cell populations have killing functions. The cultivation method for the CIK efficiently expressing CD3+CD56 comprises the following steps that the peripheral blood of a healthy person or a patient is collected in a sterile mode, after the peripheral blood is diluted through a saline solution with the same volume, a Ficoll lymphocyte separating medium is used for separating mononuclear cells, in the CIK cell inducing process, CD3 monoclonal antibodies (CD3mAb), CD28 monoclonal antibodies (CD28mAb), interferon-gamma (IFN-gamma), interleukin-2(IL-2) and interleukin 1alpha (IL-1alpha) are added, cultivation is carried out for 13-16 days to obtain cells, a CIK cell preparation is prepared, and flow cytometry detection and microorganism detection are carried out. According to the CIK cultivation method, the CIK number can be increased to be 6*10<9> or over 6*10<9> in two weeks, the cell survival rate can be increased to be 99% or over 99%, and the double-positive proportion of the CD3+CD56+cells reaches 30% or over 30%.

The invention discloses hepatic stem cell preserving solution and applications of the hepatic stem cell preserving solution. The hepatic stem cell preserving solution provided by the invention is prepared by fixing the volume of injection solution including 0.1 to 1g of human albumin, 2.60 to 4.97g of sodium chloride, 2.48 to 4.74g of sodium gluconate, 1.82 to 3.40g of sodium acetate, 0.18 to 0.35g of potassium chloride, 0.15 to 0.28g of magnesium chloride, and 0.4 to 0.7mL of heparin calcium based on effective dose by water to be reach to 100mL. The hepatic stem cell preserving solution provided by the invention is used for storing hepatic stem cells, and the survival rate of the hepatic stem cell is more than 85% and even more than 95% within 12 hours. The cell suspension which is obtained by floating the hepatic stem cells on the hepatic stem cell preserving solution can be used as the medicine for treating diabetes mellitus, and has the characteristics of being high in stability, good in curative effect, high in safety, being without toxic or side effect, convenient to store and transport, applicable to massive clinical use, and broad in application prospect. The hepatic stem cell preserving solution brings good news for diabetic patients, and provides a new way for clinical stem cell use.

The invention discloses a culture method for high-efficiency human follicle stimulating hormone expression CHO cells and belongs to the technical field of bio-pharmaceuticals. According to the culture method, seed cells are prepared into cell suspension, and subculture is performed after resuspension through a serum-free basal culture medium to obtain seed suspension; the obtained seed suspension is inoculated into a bioreactor to be cultured, the serum-free basal culture medium is fed at regular intervals in the culture process, growth situations of the cells are monitored, glucose solution is supplemented, and the cells are harvested after culture. According to the method, the serum-free basal culture medium is used throughout the process, culture in a fermentation tank is performed after reviving and amplification through bottle shaking, the process flow is simple, the cell culture density is high and can be as high as 4*107 / mL , the cell survival rate reaches more than 98%, maintaining time under high density and a high survival rate is long, the yield of end products can reach 40mg / L, and the method is applicable to industrial production.

Improved methods and pharmaceutical compositions are provided herein for mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood, comprising the administration of an effective amount of an inhibitor of GTPases, such as Rac1 and Rac2 alone or in combination. Specifically, methods are disclosed for mobilizing hematopoietic stem cells into a subject's peripheral blood. In particular, embodiments of the method involve inhibition of both Rac1 and Rac2 GTPases to increase the numbers of hematopoietic stem cells into a subject's peripheral blood of a subject. The subject's blood can be processed and used to repopulate the destroyed lymphohematopoietic system of a recipient and may in the future be utilized to repair a variety of non-hematopoietic tissues. Therefore, hematopoietic stem cells mobilized into a subject's peripheral blood by the method of the invention is useful as a source of donor cells in bone marrow transplantation for the treatment of a variety of disorders, including cancer, anemia, autoimmunity and immunodeficiency. They can also be used for increasing white blood cell survival and for chemotherapy.

The invention aims to provide an active polypeptide separated from an anchovy fermentation liquid. The molecular weight of the nerve cell injury resistant polypeptide obtained by the invention is 2,181Da; and the polypeptide is composed of 11 amino acids such as aspartic acid, threonine, glutamic acid, glycine, alanine, isoleucine, tyrosine, phenylalanine, histidine, lysine, arginine and the like, and is a novel active polypeptide with activity. According to the polypeptide obtained by the invention, in a glutamine nerve cell injury model, the addition of the active polypeptide provided by the invention can obviously increase the survival rate of PC12 nerve cells; and when the final concentration is 50 mug / mL, the cell survival rate is increased by 26.4% in comparison with an injury group, thereby effectively relieving glutamine-induced nerve cell injury. Besides, the cell mechanism study on the nerve cell protective action of the polypeptide discovers that the addition of the active polypeptide obviously increases the intracellular total oxidation resistance and has a certain promoting action on increase of SOD (superoxide dismutase) activity.

The invention discloses a cell-gel material composite microsphere as well as a preparation method and an application thereof and belongs to the field of biomedical materials. The cell-gel material composite microsphere is prepared from a gel microsphere and cells distributed in the gel microsphere. The preparation method comprises the following steps: dispersing a gel material-cell mixed solution in an oily solution, and carrying out emulsification and gelation treatment to obtain the cell-gel material composite microsphere. The cell-gel material composite microsphere is controllable in cell loading ratio, high in cell survival rate, small in volume shrinkage, difficult in breaking, good in transmitting capability of nutrients and metabolites, simple in preparation method and convenient in popularization and application and can also be used for preparing nonhomogeneous hydrogel so as to obtain a material with high biomimetic degree.

The invention discloses a serum-free culture medium for human umbilical cord MSCs (mesenchymal stem cells). The serum-free culture medium comprises the major ingredients of amino acid, inorganic salt ingredients, growth factors and albumin ingredients. The serum-free culture medium for human umbilical cord MSCs does not contain any serum ingredients; in addition, the ingredients are clear; the foreign protein pollution and pathogenic microorganism risks are avoided; the biosecurity problem of the MSCs clinic application is solved. When the serum-free culture medium provided by the invention is used for culturing the human umbilical cord MSCs, the high-quantity high-purity safe and high-quality umbilical cord MSCs can be obtained in vitro; meanwhile, the cell survival rate can be improved; the stem cell characteristics are maintained. The problem of insufficient cell quantity can be solved; the cell number, the survival rate and the immunophenotyping in each batch are more stable; the relevant index requirements are met.

The invention discloses serum-free cell cryopreservation liquid and belongs to the biotechnology field.The serum-free cell cryopreservation liquid is used for solving the problems that existing cryopreservation liquid is inconvenient to use, high in cost and low in cell survival rate.The serum-free cell cryopreservation liquid contains, by volume, 80%-89% of serum-free medium and 11%-20% of a serum and DMSO substitute.The serum and DMSO substitute contains, by volume, 30% of glycerol, 20% of chitosan and 50% of alginic acid.According to the technical scheme, use is convenient, cost is low, and cells are high in survival rate after recovery.

The invention relates to a high-precision ultrasonic anti-blocking multi-cell biological additive manufacturing method and device, and belongs to the technical field of biological additive manufacturing. A three-axis moving platform is mounted under a horizontal moving shaft, a multi-nozzle component is mounted on the horizontal moving shaft, multiple materials and cells are sprayed by piezoelectric driving and ultrasonic-assisted technology, hydrogel is transformed into sol outside the cells by a micron-sized nozzle, an ultrasonic sprayer device and an ultrasonic anti-blocking method, the cells are accurately positioned and deposited by the micron-sized nozzle, and complicated structural organs are accurately printed in a multi-material, multi-cell and high-activity manner. Reduction of printing accuracy due to enlargement of the nozzle diameter of a traditional cell printer for preventing blockage of a sprayer is avoided, limitation of multi-cell and multi-material composite printing and single-cell accurate printing is overcome, the problems of low cell survival rate and the like in the multi-cell and multi-material printing process are solved, and three-dimensional forming and integrated printing of complicated biological organ tissues are realized.

The invention discloses a rhodamine B targeted lysosome pH fluorescent probe with a cysteine ethyl ester structure, wherein the rhodamine B targeted lysosome pH fluorescent probe has the structure as shown in a formula (I). Meanwhile, the invention discloses an application of the probe as a living cell lysosome pH fluorescent probe. Experiments show that the probe provided by the invention does not generate fluorescence under the neutral and alkaline conditions, the fluorescence intensity is rapidly enhanced along with the reduction of the pH value of the solution, is up to the maximum value when the pH value is about 4.0 and is enhanced by about 150 times when the pH value ranges from 7.51 to 3.53, and the probe has favorable antijamming capability and reversibility in the presence of various metal ions. An intracellular colocalization experiment and an interlysosome pH regulation experiment prove that the probe can specially mark a lysosome and sensitively monitor the small change of the interlysosome pH value. A cell survival rate experiment shows that the probe is nontoxic to cells, which indicates that the probe disclosed by the invention has an important application value in the aspects of imaging the cells and monitoring the change of the interlysosome pH value.

The invention discloses a solid ocean red yeast preparation which is mainly prepared from a composite protective agent and ocean red yeast bacterial sludge according to a mass ratio of (1.5-2.2):1, wherein the cell density of ocean red yeast in the solid ocean red yeast preparation is 200-400 billion / gram, the cell activity is 70-80%, and the protective agent comprises skim milk powder and cane sugar. The invention further discloses a preparation method of the solid ocean red yeast preparation, The preparation method comprises the following steps: firstly, performing high-density cultivation on the ocean red yeast in a cultivation mode of continuous liquid flow layer ventilation, and further drying by using a vacuum freezing drying method. According to the solid ocean red yeast preparation, the survival rate of the ocean red yeast can be increased to be 70-80%, the cell density in the preparation can be 200-400 billion / gram, and the preparation can be also used in aquatic product feeds as an additive as a product of the preparation is in a solid manner, long in expiration date and convenient to transport.

A serum-free cryoprotectant includes: 8-15 v / v% of DMSO, 85-92 v / v% of a DMEM basic culture medium, and a nutritional additive. The nutritional additive includes: fibroblast growth factors, insulin, growth hormone, transferrin, bone morphogenetic protein 4, glutamine, sodium pyruvate, beta-mercaptoethanol, human epidermal growth factor, sodium selenite, and various amino acids and vitamins. The cryoprotectant is free of animal sourced serum and avoids pollution and risk of allergen, and has better clinical safety. The serum-free cryoprotectant is suitable for cryopreservation of human placenta sourced, umbilical cord sourced and cord blood sourced mesenchymal stem cells; compared with common serum cryoprotectants, perinatal mesenchymal stem cells preserved in the cryoprotectant have high cell survival rate after resuscitation, have excellent adherence growth status and maintain biological characters well.

The invention provides a cell cryopreservation solution prepared from components in percentage by volume as follows: 9%-13% of dimethyl sulfoxide, 2%-7% of human serum albumin and 82%-87% of a culture medium, wherein the culture medium comprises a Lonza basal culture medium and / or a DMEN high-glucose culture medium. The culture medium and the human serum albumin jointly constitute a nutritional system with rich and multiple components, stable and direct nutrition supply is provided for cells, and the cell survival rate is guaranteed. Besides, in the temperature decrease process, macromolecular substances such as protein and the like form hydrated shells, ice crystal formation is reduced, and mechanical damage and death of the cells due to ice crystal formation when the temperature decreases are avoided, so that the cell viability after long-term cryopreservation recovery is increased. Experimental results indicate that the cell recovery rate is 94%-98%, 94%-97% and 92%-94% respectively after the cryopreservation solution is used for cryopreserving the cells for 1 month, 6 months and 12 months.

The invention belongs to the field of antiviral drugs. The invention provides applications of Gramine and derivatives thereof to preparation of medicaments for resisting adenovirus Type 7. Gramine derivatives are compounds shown in G1,G2,G3,G4,G5,G10,G17,G18,G19,G20, and G21. Experiments for researching activity of Gramine derivatives for resisting ADV7, pharmacology research of Gramine derivatives for resisting ADV7, and tests of inhibition effects of G19 for ADV7 duplication show that Gramine derivatives can inhibit cytopathic effects (CPE) generated by ADV7 on host cell Hela, enhance cell survival rate, inhibit yield of progeny virus, and mainly inhibit the duplication phase of ADV7 virus in host cells. The Gramine and derivatives thereof have potential for preparing anti-ADV1 virus medicaments, and the compounds have the advantages of simple synthesis process, and economy and fastness; the compounds are easy for large-scale production, and have clinic application prospects.

The invention relates to a multi-arm polyamino acid (ester) grafted polyethyleneimine copolymer, a preparation method and application in gene delivery. The method includes the steps of: dissolving polyamine initiator in organic solvent and initiating the ring opening polymerization of alpha-amino acid-N-carboxylic acid anhydride protected by phenmethyl under anhydrous and oxygen free conditions to obtain the multi-arm polyamino acid (ester); and then causing the full or partial aminolysis reaction to occur between benzyl ester at the lateral chain of the multi-arm polyamino acid (ester) and amino group of polyethyleneimine to form the grafted copolymer. The polymer is a novel high-efficiency polycation gene vector, integrates the properties of polyethyleneimine and polyamino acid and is high in transfection efficiency, and the highest transfection efficiency to the mediate luciferase plasmid of Chinese Hamster Ovary epithelial cell is ten times than that of the Lipofectamine2000 of the commercial transfection reagent in US Invitrogen biomax under the same conditions; cytotoxicity is small; and cell survival rate is over 80% within the best transfection rate range, thus having broad application prospect.

The invention relates to the technical field of biology, specifically discloses a serum-free protein-free cell culture medium, and aims to provide a serum-free protein-free cell culture medium capable of supporting the growth of high density cells. The culture medium comprises amino acids, vitamins, inorganic salts, trace elements, carbohydrates, other chemical compounds, polyamine (or derivatives of polyamine), and hydrolysate. The manufacturing cost is low. The stability is high, the live cell density and cell survival rate are extremely high, and the culture medium is suitable for culture cells for recombinant protein and vaccine production.

The invention belongs to the technical field of cell electrotransfection and specifically relates to cell electrotransfection device and application thereof. The cell electrotransfection device at least comprises an electrotransfection control circuits, two electrodes and an electrotransfection container. The two electrodes are connected to a power supply in the electrotransfection control circuit. One of the two electrodes is used as a positive electrode, and the other electrode is used as a negative electrode. The two electrodes are arranged inside the electrotransfection container. One or two of the electrodes possess a nanowire structure on the surface thereof. The cell electrotransfection device of the invention can be used for electrotransfection of various cells. In addition, cells survival rate is high, and the electrotransfection effect is good. The cell electrotransfection device has high application value.

The invention provides an improved mesenchymal stem cell protective solution. The concentration of electrolytes in an unfrozen water solution inside and outside cells is balanced through a permeatingprotective agent, so that cell damage due to excessive dehydration of cells in the outside high-permeability environment is avoided; added protein composition can supply cells with required nutrients,and accordingly, the cell survival rate is increased; a physiological activity inhibitor of cells can reversibly inhibit physiological activities in the cells, and the cryopreservation effect is improved on the premise that the cell activity is not affected; amifostine is a broad-spectrum cell protective agent and a radiation protective agent and can improve the tolerance of cells to the outsideadverse environment, reduce accumulation of toxic substances in cells and improve the proliferative activity of stem cells. Through combined use of components, the stress resistance of mesenchymal stem cells can be effectively improved, cell activity loss caused in the cryopreservation process can be reduced, and the cell survival rate and the thawing rate after cryopreservation are increased.

The invention relates to an MTT (thiazolyl blue) cell toxicity test method of biological assessment of a total particle matter in cigarette smoke and belongs to the technical field of safety assessment of tobacco and cigarette smoke. The MTT cell toxicity test method is characterized by comprising the following steps of: inoculating and culturing immortalized human bronchial epithelial cells (BEAS-2B cells) and contaminating the total particle matter in the cigarette smoke; detecting the cell survival rate by adopting an MTT method; and analyzing and evaluating the cell toxicity of the total particle matter in the cigarette smoke according to a test result. Compared with the prior art, the MTT cell toxicity test method has the following characteristics that BEAS-2B cells are human cells and are target organ source cells acting on a human body by the smoke; a BEAS-2B cell system is used for carrying out cell toxicity assessment on the cigarette smoke and has the strong pertinence; in a testing process, steps of washing the cells for a plurality of times are reduced; and a formaldehyde fixing step does not need to be carried out so that a testing period is shortened, the operation is rapid and convenient, the sensitivity is high and the result is stable and reliable. Moreover, the MTT test method disclosed by the invention is further applicable to a smoke cell toxicity test of various cell systems and the commonality is strong.

The invention discloses an optimum design method for a piezoelectric type sprayer for printing cells. The optimum design method is mainly utilized to solve the problems that a spraying hole is easily plugged and the survival rate of cells is low when a present piezoelectric type sprayer is used for printing the cells. The method comprises the following steps: solving a speed of an appointed node on the basis of a structural limited element model of a piezoelectric actuator; establishing a computational fluid dynamic model of the sprayer and solving according to an initial parameter and the obtained speed to obtain a condition for drop forming and the pressure of each part in the sprayer; solving a pressure wave period according to the obtained pressure, correspondingly adjusting a voltage pulse width and solving a corresponding result again; and by aiming at the demand of a user on the drop forming, establishing an optimized mathematical model and utilizing a value optimizing algorithm to solve to obtain a design parameter which meets the demand of the user and has the minimal passage maximum pressure and design the piezoelectric type sprayer. According to the optimum design method, the problems that the spraying hole is plugged and the survival rate of cells is low when the piezoelectric type sprayer is used for printing a high-viscosity cell solution are solved, and the electromechanical integrated design of the sprayer is realized.

The invention relates to a method for extracting phenolic glycoside compounds from semen lepidii and application thereof, which can effectively obtain the new function of the semen lepidii. The method adopts the technical scheme that the molecular formula of a semen lepidii new glycoside A is C18H24O12[M+Na]<+>m / z 455.1196; the molecular formula of a semen lepidii new glycoside B is C18H24O12[M+Na]<+>m / z 455.1202. The method has the advantages that two new phenolic glycoside compounds are extracted from a water extract of the semen lepidii, namely the semen lepidii new glycoside A and the semen lepidii new glycoside B; by adopting the two new phenolic glycoside compounds, the cell survival rate of the injured hydrogen peroxide-induced rat myocardial cell H9c2 is obviously improved; the function of protecting the myocardial cell is realized, and a new path is provided for preparation of myocardial protection drugs.

The invention provides a cell-biomaterial composite support frame. The composite support frame comprises a support frame base body and viscous cell suspension capable of slowly releasing cells, wherein the composite support frame forms the AC<n>B distribution formation from bottom to top, wherein the A is a support frame base body layer; the B is a viscous cell suspension layer; the C is a mixing layer formed by the viscous cell suspension through crossed distribution in support frame base body gaps; the n is a positive integer from 3 to 20; the viscous cell suspension comprises cells, cell carrying carriers and water; and the carriers are biocompatible viscous materials. The distribution density of the ells on the composite support frame is controllable; the adherence rate and the cell survival rate are high; and the problems of weak tissue regeneration promoting capability, weak proliferation and differentiation and slow growth of the cells on a three-dimensional composite support frame can be solved. The invention also provides a preparation method and application of the composite support frame.